Allan Evans - Oct 30, 2024 Form 4 Insider Report for Unusual Machines, Inc. (UMAC)

Role
Chief Executive Officer, Director
Signature
/s/ Allan Evans
Stock symbol
UMAC
Transactions as of
Oct 30, 2024
Transactions value $
$199,999
Form type
4
Date filed
10/31/2024, 04:02 PM
Previous filing
May 28, 2024
Next filing
Nov 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UMAC Common Stock Purchase $100K +65.8K +263.16% $1.52 90.8K Oct 30, 2024 Direct F1
holding UMAC Common Stock 529K Oct 30, 2024 By: 8 Consulting LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UMAC Warrants Purchase $100K +65.8K $1.52 65.8K Oct 30, 2024 Common Stock 65.8K $1.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 29, 2024, the Issuer and the Reporting Person entered into a Securities Purchase Agreement (the "SPA"), pursuant to which the Reporting Person purchased 65,789 units, each unit consisting of one share of common stock and one warrant, from the Issuer in a private placement in reliance upon the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933 and Rule 506 promulgated thereunder. The transaction contemplated by the SPA closed on October 30, 2024 (the "Closing Date").
F2 The shares are held by 8 Consulting LLC, which the Reporting Person is the sole owner and holds voting and dispositive control.
F3 The warrants may not be exercised for 180 days after the Closing Date, so the Reporting Person is not deemed to be the beneficial owner of the underlying shares of common stock. The warrants contain beneficial ownership limitations preventing the Reporting Person from owning in excess of 4.99% or 9.99% of outstanding shares of common stock at any given time and, subject to shareholder approval, 19.99% of all current outstanding common stock currently outstanding or such lesser percentage required by the NYSE American without first obtaining stockholder approval in accordance with the NYSE American rules.